GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of week 59 check-in — 30kg down, nausea manageable, one thing confusing me — 59 comments in the full submission. View in context.
1.6k
c/tapering·submitted 6 months ago by u/lina_adebayo

week 59 check-in — 30kg down, nausea manageable, one thing confusing me

Trial Databranch of 7 comments

Here it is: week 59 check-in — 30kg down, nausea manageable, one thing confusing me. One person, one log, no control group, so read it accordingly. week 59 and 30kg — those are the numbers, and they are the ones I am willing to defend. A written baseline — dose, date, weight, waist, and how appetite feels — taken…

Read the full submission and all 59 comments →

This branch

7 comments, started 6 months ago
u/adaeze_brandt69 points·6 months ago

Stretching the interval or reducing the dose?

replysharereportpermalink
u/ferran_krastev33 points·6 months ago

Stretching the interval or reducing the dose?

Disagreeing with this bit: stretching and reducing are different things and the post treats them as one.

replysharereportpermalink
[deleted]14 points·6 months ago

[deleted]

replysharereportpermalink
u/micro_bump_mick19 points·6 months ago

stopping abruptly and stopping gradually are different experiences

replysharereportpermalink
u/ilias_kaufmann12 points·6 months ago

a fortnight of nothing is not evidence that you are fine

replysharereportpermalink
u/zeynep_zielinski6 points·6 months ago

Agreed. Appetite is the leading indicator and the scale is the lagging one. Watch the first, not the second.

replysharereportpermalink
u/zeynep_ndiaye-6 points·6 months ago

Stretched from seven days to ten to twelve over four months. Appetite told me where the limit was each time.

replysharereportpermalink

← back to the whole thread

About c/tapering

Stopping on purpose: dose reduction versus interval stretching, what the discontinuation arms of STEP 1 and SURMOUNT-4 actually showed about regain, appetite return timelines, and the people who came off, regained, and went back on without treating it as a failure.

20kmembers
62submissions
Jun 2024created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/tapering rules
  1. Cite the discontinuation data rather than guessing at regain rates.
  2. No shaming people who restart.
  3. Say how long you were on and at what dose before you tapered.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.